Ingredient or product comparison
Comparison: GHK-Cu vs Standard Brightening Agents
GHK-Cu (3–5%) MITF transcription suppression + copper-dependent enzyme activation 6–8 weeks Minimal Low (< 5% irritation rate in trials) Safe with retinoids, niacinamide, vitamin C when sequenced properly Hydroquinone (4%) Irreversible tyrosinase inhibition 2–
This source-based comparison does not add ratings or recommend a winner.
- GHK-Cu (3–5%)
- MITF transcription suppression + copper-dependent enzyme activation
- 6–8 weeks
- Minimal
- Low (< 5% irritation rate in trials)
- Safe with retinoids, niacinamide, vitamin C when sequenced properly
- Hydroquinone (4%)
- Irreversible tyrosinase inhibition
- 2–4 weeks
- High (23% rebound rate)
- Moderate (10–15% irritation, risk of ochronosis with long-term use)
- Not recommended with retinoids or acids due to irritation compounding
- Kojic Acid (2–4%)
- Competitive tyrosinase inhibition
- 4–6 weeks
- Moderate
- Moderate (sensitisation in 8–12% of users)
- Generally safe but can increase photosensitivity
- Vitamin C (15–20%)
- Antioxidant interference with melanin oxidation
- 8–12 weeks
- High at effective concentrations (oxidation causes irritation)
- Unstable in formulations with copper peptides unless stabilised
- Tranexamic Acid (3–5%)
- Plasmin inhibition (blocks UV-induced melanocyte activation)
- 8–10 weeks
- Low
- Very low
- Excellent combination partner with GHK-Cu for melasma
- Bottom Line
- GHK-Cu offers the best risk-benefit ratio for maintenance brightening and post-inflammatory hyperpigmentation prevention. It's slower than hydroquinone but safer for long-term use and doesn't cause rebound. For acute melasma treatment, hydroquinone remains more effective initially, but transitioning to GHK-Cu for maintenance prevents relapse.